SEC Filing Details

SEC Filing Details

Document Details

Form

Filing Date

Jan 18, 2024

Document Date

Jan 11, 2024

Form Description

Report of unscheduled material events or corporate event

Filing Group

Current Reports

Company

ReShape Lifesciences

Issuer

RESHAPE LIFESCIENCES INC.

Filing Formats

View HTML

XBRL

XBRL Viewer

EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA

EX-101.LAB - EX-101.LAB

EX-101.PRE - EX-101.PRE

XML - XBRL INSTANCE DOCUMENT

For investor inquiries, please contact:

ReShape Lifesciences Investor Contact:
Thomas Stankovich
Chief Financial Officer
949-276-6042
ir@ReShapeLifesci.com

Investor Contacts:
Rx Communications Group
Michael Miller
917-633-6086
mmiller@rxir.com

PRINT PAGE

EMAIL PAGE